nejm semaglutide ckd Updates in Medicine | 🩺 Oral Cuts CV Risk in High-Risk T2DM – SOUL Trial (NEJM, Mar 2025) 🔗 Original article link in bio 📌 Key Highlights: 🔹 Semaglutide in patients with overweight

In theory, this could pave the way for even greater efficacy for GLP-1 treatments while also achieving an important reduction in the currently high rate of adverse GI events

Researchers using a 5-day-on, 2-day-off cycling protocol report more consistent onset windows than those using KLOW daily without breaks

This helps the body adjust and may reduce side effects

While taking GLP-1 medications in a caloric deficit, resistance training will preserve your existing muscle and create a more toned, defined appearance as body fat decreases

Stomach pain occurs primarily because Ozempic slows down food movement through the digestive system

population received a prescription for one of these medications in 2023